申请人:TOA Eiyo Ltd.
公开号:EP3106455A1
公开(公告)日:2016-12-21
Provided is a novel compound having an excellent suppression effect against arrhythmia including atrial fibrillation and being useful as a pharmaceutical product without antiviral effect. Disclosed is a compound represented by the following General Formula (I), a pharmaceutically acceptable salt thereof, or a solvate thereof (in the formula, the dotted line portion represents a single bond or a double bond; R1 represents an optionally substituted C1-6 alkyl group; Q represents an oxygen atom, a sulfur atom, or NR5; R2 represents - (C=O)-R6, -CHR6R7, or-CH2OR8; and R3 and R4, which may be identical or different, each represent an amino group, an azide group, or -X-R9, with the proviso that any one of R3 and R4 is an amino group).
本发明提供了一种新型化合物,该化合物对包括心房颤动在内的心律失常具有极佳的抑制作用,可用作无抗病毒作用的药物。本发明公开了由以下通式(I)表示的化合物、其药学上可接受的盐或其溶液(式中,虚线部分代表单键或双键;R1 代表任选取代的 C1-6 烷基;Q 代表氧原子、硫原子或 NR5;R2 代表- (C=O)-R6、-CHR6R7 或-CH2OR8;以及 R3 和 R4(可以相同或不同)各自代表氨基、叠氮基团或-X-R9,但 R3 和 R4 中的任何一个是氨基)。